Mirabegron improves the irritative symptoms caused by BCG immunotherapy after transurethral resection of bladder tumors

Mirabegron improves the irritative symptoms caused by BCG immunotherapy after transurethral resection of bladder tumors

Abstract Background This study aims to explore the efficacy and safety of mirabegron in treating irritative symptoms induced by intravesical immunotherapy with Bacillus Calmette–Guerin (BCG) after transurethral resection of bladder tumors (TURBT). Methods A total of 160 patients subjected to TURBT w...

Full description

Bibliographic Details
Main Authors: Kai Sun, Di Wang, Gang Wu, Jian Ma, Tianqi Wang, Jitao Wu, Jipeng Wang
Format: Article
Language:English
Published: Wiley 2021-11-01
Series:Cancer Medicine
Subjects:
BCG immunotherapy
irritative symptoms
mirabegron
Online Access:https://doi.org/10.1002/cam4.4278

Internet

https://doi.org/10.1002/cam4.4278

Similar Items